XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Parent
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Deferred Compensation Employee Stock Trust, Net
Employee Stock Trust
Noncontrolling Interest
Total
Increase (Decrease) in Stockholders' Equity                  
Adoption of accounting standards $ 1,393       $ 1,393       $ 1,393
Balance at Dec. 31, 2018 1,949,470 $ 936 $ 1,489,816 $ (8,627) 466,737 $ 825 $ (217) $ 24,423 1,973,893
Balance (in shares) at Dec. 31, 2018   93,610,000         11,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 96,597       96,597     2,971 99,568
Other comprehensive income 16,489     16,489         16,489
Stock-based compensation expense 4,739   4,739           4,739
Common stock issued to board members 281   281           281
Common stock issued to board members (in shares)   15,000              
Issuance of common stock related to share-based awards, net (1,734) $ 4 (1,738)           (1,734)
Issuance of common stock related to share-based awards, net (in shares)   365,000              
Repurchases of common stock (24,980) $ (12) (19,499)   (5,469)       (24,980)
Repurchases of common stock (in shares)   (1,215,000)              
Dividends on common stock (14,983)       (14,983)       (14,983)
Deferred compensation plan 9         (37) $ 46   9
Deferred compensation plan (in shares)             (2,000)    
Net cash distributed to noncontrolling interest               (2,870) (2,870)
Balance at Jun. 30, 2019 2,027,281 $ 928 1,473,599 7,862 544,275 788 $ (171) 24,524 2,051,805
Balance (in shares) at Jun. 30, 2019   92,775,000         9,000    
Balance at Mar. 31, 2019 1,991,527 $ 938 1,491,585 (1,062) 499,452 827 $ (213) 23,604 2,015,131
Balance (in shares) at Mar. 31, 2019   93,821,000         11,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 57,811       57,811     1,980 59,791
Other comprehensive income 8,924     8,924         8,924
Stock-based compensation expense 2,385   2,385           2,385
Common stock issued to board members 141   141           141
Common stock issued to board members (in shares)   7,000              
Issuance of common stock related to share-based awards, net (1,011) $ 2 (1,013)           (1,011)
Issuance of common stock related to share-based awards, net (in shares)   162,000              
Repurchases of common stock (24,980) $ (12) (19,499)   (5,469)       (24,980)
Repurchases of common stock (in shares)   (1,215,000)              
Dividends on common stock (7,519)       (7,519)       (7,519)
Deferred compensation plan 3         (39) $ 42   3
Deferred compensation plan (in shares)             (2,000)    
Net cash distributed to noncontrolling interest               (1,060) (1,060)
Balance at Jun. 30, 2019 2,027,281 $ 928 1,473,599 7,862 544,275 788 $ (171) 24,524 2,051,805
Balance (in shares) at Jun. 30, 2019   92,775,000         9,000    
Increase (Decrease) in Stockholders' Equity                  
Adoption of accounting standards (5,691)       (5,691)       (5,691)
Balance at Dec. 31, 2019 2,103,039 $ 906 1,445,233 11,419 644,860 776 $ (155) 25,757 2,128,796
Balance (in shares) at Dec. 31, 2019   90,641,000         8,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 178,112       178,112     10,905 189,017
Other comprehensive income 12,394     12,394         12,394
Stock-based compensation expense 6,759   6,759           6,759
Common stock issued to board members 292   292           292
Common stock issued to board members (in shares)   18,000              
Issuance of common stock related to share-based awards, net (1,024) $ 3 (1,027)           (1,024)
Issuance of common stock related to share-based awards, net (in shares)   284,000              
Repurchases of common stock (15,249) $ (7) (11,571)   (3,671)       $ (15,249)
Repurchases of common stock (in shares)   (721,000)             (720,901)
Dividends on common stock (16,279)       (16,279)       $ (16,279)
Deferred compensation plan 7         2 $ 5   7
Net cash distributed to noncontrolling interest               (6,889) (6,889)
Balance at Jun. 30, 2020 2,262,360 $ 902 1,439,686 23,813 797,331 778 $ (150) 29,773 2,292,133
Balance (in shares) at Jun. 30, 2020   90,222,000         8,000    
Balance at Mar. 31, 2020 2,136,711 $ 901 1,437,301 20,939 676,946 774 $ (150) 27,022 2,163,733
Balance (in shares) at Mar. 31, 2020   90,108,000         8,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 128,476       128,476     6,939 135,415
Other comprehensive income 2,874     2,874         2,874
Stock-based compensation expense 3,117   3,117           3,117
Common stock issued to board members 146   146           146
Common stock issued to board members (in shares)   8,000              
Issuance of common stock related to share-based awards, net (555) $ 1 (556)           (555)
Issuance of common stock related to share-based awards, net (in shares)   126,000              
Repurchases of common stock (292)   (322)   30       (292)
Repurchases of common stock (in shares)   (20,000)              
Dividends on common stock (8,121)       (8,121)       (8,121)
Deferred compensation plan 4         4     4
Net cash distributed to noncontrolling interest               (4,188) (4,188)
Balance at Jun. 30, 2020 $ 2,262,360 $ 902 $ 1,439,686 $ 23,813 $ 797,331 $ 778 $ (150) $ 29,773 $ 2,292,133
Balance (in shares) at Jun. 30, 2020   90,222,000         8,000